| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000007591 |
| Receipt No. | R000008925 |
| Official scientific title of the study | Randomized Controlled Trial to evaluate the efficiency of absorbable barbed suture (V-Loc180) during Laparoscopic Myomectomy |
| Date of disclosure of the study information | 2012/03/29 |
| Last modified on | 2016/09/30 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Randomized Controlled Trial to evaluate the efficiency of absorbable barbed suture (V-Loc180) during Laparoscopic Myomectomy | |
| Title of the study (Brief title) | Randomized Controlled Trial to evaluate the efficiency of absorbable barbed suture (V-Loc180) during Laparoscopic Myomectomy | |
| Region |
|
|
| Condition | ||
| Condition | Uterine myoma | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The objective of this study was to confirm the superiority of a test treatment group using V-Loc180 to a current standard of care group using a multifilament suture Polysorb in patients undergoing Laparoscopic Myomectomy, using a randomized comparative study of the suturing time in the uterine wall defect etc. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Suturing time in the uterine wall defect |
| Key secondary outcomes | Blood loss
Amount of drainage Duration of drain placement Length of hospital stay Adverse events(intraoperative and postoperative) Degree of adhesion formation by second-look Number of sutures used |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Group A:V-Loc180 | |
| Interventions/Control_2 | Group B:Polysorb | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1) Interstitial myoma of the uterus
2) Myomas can be closed with single layer suture 3) Within 3 uterine fibroids 4) Within a 10cm. uterine fibroid in diameter 5) No history of gynecological surgery(myomectomy, systectomy) 6) Healthy organ function 7) Obtained the written informed consent |
|||
| Key exclusion criteria | 1) Active bacterial infection or fungal infection
2) Under continuing systemic administration (intravenous or oral) of steroids 3) Complicated condition with uncontrolled diabetes mellitus(HbA1c >8.0%). 4) Judged difficulty due to study complications related to a psychiatric disorder or psychological symptoms 5) Judged unsuitable patient for study participation by the investigator for any other reason |
|||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Iwaho Kikuchi M.D. |
| Organization | Juntendo UniversityHospital |
| Division name | Department of Obstetrics and Gynecology |
| Address | Hongo 3-1-3, Bunkyo-ku, Tokyo 113-8431, Japan |
| TEL | |
| Public contact | |
| Name of contact person | Iwaho Kikuchi M.D. |
| Organization | Juntendo UniversityHospital |
| Division name | Department of Obstetrics and Gynecology |
| Address | Hongo 3-1-3, Bunkyo-ku, Tokyo 113-8431, Japan |
| TEL | |
| Homepage URL | |
| Sponsor | |
| Institute | Juntendo UniversityHospital
Department of Obstetrics and Gynecology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Covidien Japan Inc. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000008925 |